Status:
COMPLETED
Comparison of Propofol Requirement Between Patients With Pituitary Somatotroph Tumor and With Nonfunctioning Pituitary Tumor in Transsphenoidal Pituitary Surgery Under Total Intravenous Anesthesia
Lead Sponsor:
Yonsei University
Conditions:
Pituitary Tumor
Eligibility:
All Genders
19+ years
Brief Summary
Investigators hypothesized that propofol dose for pituitary somatotroph patients might differ from nonfunctioning pituitary tumor, and investigators will evaluate a target controlled infusion (TCI) ef...
Eligibility Criteria
Inclusion
- patients with pituitary somatotroph tumor and with nonfunctioning pituitary tumor in transsphenoidal pituitary surgery
- American society of anesthesiologists classification 1 or 2
Exclusion
- left ventricle ejection fraction \< 55% 3RD degree AV block, 2nd degree AV block with P:QRS \> 3:1
- serum Creatinine \> 1.0mg/dl
- myocardial infarction or cerebral stroke in 1 yrs
- fever \> 38C
- dementia, cognitive disorder, confused mental status
- pregnant patients
- allergic to propofol
- illiteracy or foreigners
Key Trial Info
Start Date :
March 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 4 2018
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03465423
Start Date
March 20 2018
End Date
December 4 2018
Last Update
February 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Associate Professor Department of Anesthesiology and Pain Medicine
Seoul, South Korea, 120-752